Injection of dexmedetomidine in reduction of pain in pediatrics tonsillectomy

Submucosal injection of dexmedetomidine in reduction of postoperative pain in pediatric tonsillectomy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220508054785N1

Enrollment

Registered

2022-08-31

Start date

2022-10-23

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tonsillectomy.

Interventions

Intervention 1: Intervention group: anaesthesia is induced by fentanyl 4 µg/kg &and propefol 2 µg/kg & atracurium 0.4 µg/kg after 3 minutes tracheal intubation and ventilation are performed and anaes

Eligibility

Sex/Gender

All

Age

4 Years to 15 Years

Inclusion criteria

Inclusion criteria: Candidate for tonsillectomy surgery 4 to 15 years ASA class I&II No peritonsillar abscess No chronic pain Not taking painkillers 24 hours before surgery

Exclusion criteria

Exclusion criteria: Parents' lack of consent to continue attending the study History of allergy to any medicine Coagulation disorder Liver disorders Uncontrolled diabetes (ASA 3 and above) Active upper respiratory tract infection Occurrence of complications during surgery Increasing the recovery period to more than 60 minutes Increasing the duration of surgery

Design outcomes

Primary

Measure	Time frame
Severity of pain after tonsil surgery. Timepoint: 4, 8, 12 and 24 after the intervention. Method of measurement: Faces Pain Scale-Revised (FPS-R).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShakiba mozari

Sabzevar University of Medical Sciences

sh.mozari@gmail.com+98 51 4401 8300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026